John de Koning is a Partner at Eqt Life Sciences, whose known portfolio counts 10 companies.
Is John de Koning a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Partner at Eqt Life Sciences, whose known portfolio counts 10 companies
- ONWARD
- Tubulis
- Artios Pharma
- Tenpoint Therapeutics
- Electra Therapeutics
- Exciva
- Kinaset Therapeutics
- FoRx Therapeutics
- Neurent Medical
- Xeltis
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Clinical Trials, Drug Discovery and Genetics. Startups operating in these areas may find John de Koning relevant.
Eqt Life Sciences appears in Growth, Late-Stage and Series A rounds across its known deals.
The firm portfolio and the focus above give founders context on whether John de Koning matches their raise.
Colleagues at Eqt Life Sciences
Merijn Klaassen
CFO & COO EQT Life Sciences (formerly LSP)
Tilburg, Netherlands
Cillian King
Investor
Amsterdam, Netherlands
Fouad Azzam
Partner
Boston, United States
Anne Portwich
Partner
Amsterdam, Netherlands
Daniela Begolo
Managing Director
Amsterdam, Netherlands
Maximilian Moser
Vice President
London, United Kingdom
Philipp Bräuer
Vice President
Munich, Germany
Juliette Lee
VP
Amsterdam, Netherlands
Bruno Holthof
Partner
Oxford, United Kingdom
René Kuijten
Head of Life Sciences
Amsterdam, Netherlands
Drew Burdon
Partner
United Kingdom
Christoph Broja
Partner
Germany
Roberta Ferrari
Managing Director
United Kingdom
Laurenz Govaerts
Director
Brussels, Belgium
Kevin Hammon
Vice President
Boston, United States
Frequently asked questions
Who is John de Koning?
John de Koning is a private equity investor and venture capital investor based in Amsterdam, North Holland, Netherlands, listed as Partner at Eqt Life Sciences. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to John de Koning personally.
What does John de Koning invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Drug Discovery and Genetics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does John de Koning invest at?
Eqt Life Sciences appears in Growth, Late-Stage and Series A rounds across its known deals, and John de Koning is listed there as Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is John de Koning listed at?
John de Koning is listed as Partner at Eqt Life Sciences. 15 other people in the database share a firm with John de Koning.
How do I contact John de Koning?
An email address, a phone number and a LinkedIn page are on file for John de Koning. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal